Providing Guidance and Support for all KPNW Research Compliance Activities

  Announcements

Andrea Seykora, Research Compliance Manager, will be on parental leave from early October – early January

In her absense, please use the following contacts:

IRB review or eIRB system
Kaija Maggard, IRB Manager
Kaija.H.Maggard@kpchr.org
503-335-6699

Data/specimen sharing (including agreements and compliance Manager access); FCOI; QI Monitoring Program
Melinda Allie, Quality Improvement Compliance Coordinator
Melinda.J.Allie@kpchr.org
503-335-6753

Unauthorized disclosures of PHI; other compliance questions​
Research Compliance Committee
CHR_Compliance@kpchr.org
Urgent issues only:  Don Freel at 503-335-6702

Next IRB meeting: December 20, 2017

Submissions for review at the December 2017 IRB meeting should be submitted through the electronic IRB system (eIRB) by the end of work on 12/1/2017.

RE: Continuing Review Submissions: It is the Principal Investigator's responsibility to submit a report for continuing review by the submission deadline.

The eIRB sends courtesy reminders to the study team when a continuing review submission is due. Reminders are sent at 90, 60, and 30 days prior to the approval expiration date. These are the only reminders the study team will receive.

Reminders are discontinued after a continuing form has been opened. If you create a continuing review in the eIRB when you receive the 90-day reminder, you will not receive additional reminders at 60 and 30 days.

Your Feedback Requested!

Help the Research Compliance team by completing an anonymous survey about your experience with the Research Compliance Department's customer service.  We appreciate your input!

Click here to access the survey.

Compliance Committee Meeting Schedule

  • CHR Research Compliance Committee (local/NW) meets the second Wed of the month.
  • Hawaii CHR representatives join the committee on a quarterly basis.

View 2017 RCC Charter & Membership

Welcome Kaiser Permanente Washington!

Group Health is now Kaiser Permanente Washington. The eIRB system has been updated to reflect this change. Remember to search for "Kaiser Permanente Washington IRB" on the picklist when submitting a request for KPNW to rely on the KP Washington IRB for review of a study. All references in new study applications should be to KP Washington.

Updating Existing Studies Conducting Collaborative Research with KP Washington

Study teams should update references to Group Health in the application form with the next submission to modify the study. If the next submission is for contining review, submit a combined modification and continuing review. It is not necessary to submit a study modification solely to make the update.

For existing studies ceded to Group Health, the eIRB automatically updated the name in the External IRB section of the application.

Data or Specimen Sharing Agreements with KP Washington

Please use the full KP DUA, DTA, or MDTA templates when developing new sharing agreements with KP Washington.

eIRB

Designed to enable researchers and IRB reviewers to manage all aspects of the Institutional Review Board (IRB) Administration process.

Research Compliance Newsletter

Fall 2017 Newsletter Archive

For IRB Members

Find information and documentation to support the following tasks:

Study Reviews

IRB Member Orientation

About Research Compliance & IRB


The Research Subjects Protection Office (RSPO) is an administrative office for the Institutional Review Board (IRB) at Kaiser Permanente Northwest (KPNW).

Learn More

Resources & References


Find useful information about ethical principles, federal regulations, genetic research, informed consent readability and more.

Browse

Policies & Procedures


Find vital information about Financial Conflicts of Interest, FDA-Regulated Clinical Trials, Privacy Policies, Research Integrity, Security, and Human Research Protection.

Browse